Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress

Margarita E. Neganova; Sergey G. Klochkov; Yulia R. Aleksandrova; Gjumrakch Aliev

doi:10.1016/j.semcancer.2020.07.015

journal article Aug 01, 2022

Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress

Margarita E. Neganova Sergey G. Klochkov Yulia R. Aleksandrova Gjumrakch Aliev

Seminars in Cancer Biology Vol. 83 pp. 452-471 · Elsevier BV

View at Publisher Save 10.1016/j.semcancer.2020.07.015

Topics

No keywords indexed for this article. Browse by subject →

References

302

[1]

Heron "Deaths: leading causes for 2009" Vital Stat. Rep. (2012)

[2]

Park "Targeting epigenetics for cancer therapy" Arch. Pharm. Res. (2019) 10.1007/s12272-019-01126-z

[3]

Torre "Lung Cancer statistics" Adv. Exp. Med. Biol. (2016) 10.1007/978-3-319-24223-1_1

[4]

Vogelstein "Cancer genome landscapes" Science (2013) 10.1126/science.1235122

[5]

Bos "Ras oncogenes in human cancer: a review" Cancer Res. (1989)

[6]

Klochkov "Implications of farnesyltransferase and its inhibitors as a promising strategy for cancer therapy" Semin. Cancer Biol. (2019) 10.1016/j.semcancer.2017.10.010

[7]

Gonzaga-Jauregui "Human genome sequencing in health and disease" Annu. Rev. Med. (2012) 10.1146/annurev-med-051010-162644

[8]

Hood "The Human Genome Project: big science transforms biology and medicine" Genome Med. (2013) 10.1186/gm483

[9]

Sheikh "A proteomics based approach for the identification of gastric cancer related markers" Curr. Pharm. Des. (2016) 10.2174/1381612822666151209151848

[10]

Chabanon "Exploiting epigenetic vulnerabilities in solid tumors: novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers" Semin. Cancer Biol. (2020) 10.1016/j.semcancer.2019.09.018

[11]

Dawson "Cancer epigenetics: from mechanism to therapy" Cell (2012) 10.1016/j.cell.2012.06.013

[12]

Kanwal "Epigenetics and cancer" J. Appl. Physiol. (2010) 10.1152/japplphysiol.00066.2010

[13]

Sharma "Epigenetics in cancer" Carcinogenesis (2010) 10.1093/carcin/bgp220

[14]

Cacabelos "Novel therapeutic strategies for dementia" CNS Neurol. Disord. Drug Targets (2016) 10.2174/1871527315666160202121548

[15]

Werner "Epigenetics and precision oncology" Cancer J. (2017) 10.1097/ppo.0000000000000281

[16]

Qin "Histone modifications and their role in colorectal Cancer (Review)" Pathol. Oncol. Res. (2019)

[17]

Kouzarides "Chromatin modifications and their function" Cell (2007) 10.1016/j.cell.2007.02.005

[18]

Prachayasittikul "Exploring the epigenetic drug discovery landscape" Expert Opin. Drug Discov. (2017) 10.1080/17460441.2017.1295954

[19]

Dekker "Histone acetyl transferases as emerging drug targets" Drug Discov. Today (2009) 10.1016/j.drudis.2009.06.008

[20]

Onufriev "The nucleosome: from structure to function through physics" Curr. Opin. Struct. Biol. (2019) 10.1016/j.sbi.2018.11.003

[21]

Fyodorov "Emerging roles of linker histones in regulating chromatin structure and function" Nat. Rev. Mol. Cell Biol. (2018) 10.1038/nrm.2017.94

[22]

Di Martile "The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target" Oncotarget (2016) 10.18632/oncotarget.10048

[23]

Narita "Author Correction: Functions and mechanisms of non-histone protein acetylation" Nat. Rev. Mol. Cell Biol. (2019) 10.1038/s41580-019-0156-9

[24]

Sapountzi "MYST-family histone acetyltransferases: beyond chromatin" Cell. Mol. Life Sci. (2011) 10.1007/s00018-010-0599-9

[25]

Barnes "Acetylation & Co: an expanding repertoire of histone acylations regulates chromatin and transcription" Essays Biochem. (2019) 10.1042/ebc20180061

[26]

Trefely "Crosstalk between cellular metabolism and histone acetylation" Methods Enzymol (2019) 10.1016/bs.mie.2019.07.013

[27]

Yang "HAT4, a Golgi apparatus-anchored B-type histone acetyltransferase, acetylates free histone H4 and facilitates chromatin assembly" Mol. Cell (2011) 10.1016/j.molcel.2011.07.032

[28]

Tafrova "Human histone acetyltransferase 1 (Hat1) acetylates lysine 5 of histone H2A in vivo" Mol. Cell. Biochem. (2014) 10.1007/s11010-014-2036-0

[29]

Dancy "Correction to protein lysine acetylation by p300/CBP" Chem. Rev. (2016) 10.1021/acs.chemrev.6b00351

[30]

Salah Ud-Din "Structure and functional diversity of GCN5-Related N-Acetyltransferases (GNAT)" Int. J. Mol. Sci. (2016) 10.3390/ijms17071018

[31]

Wang "Functions of SAGA in development and disease" Epigenomics (2014) 10.2217/epi.14.22

[32]

Hsieh "The TFIIIC90 subunit of TFIIIC interacts with multiple components of the RNA polymerase III machinery and contains a histone-specific acetyltransferase activity" Mol. Cell. Biol. (1999) 10.1128/mcb.19.11.7697

[33]

Guo "The histone acetylation modifications of breast Cancer and their therapeutic implications" Pathol. Oncol. Res. (2018) 10.1007/s12253-018-0433-5

[34]

Shanmugam "Correction: role of novel histone modifications in cancer" Oncotarget (2018) 10.18632/oncotarget.25152

[35]

Calcagno "Role of histone acetylation in gastric cancer: implications of dietetic compounds and clinical perspectives" Epigenomics (2019) 10.2217/epi-2018-0081

[36]

Gruber "HAT1 coordinates histone production and acetylation via H4 promoter binding" Mol. Cell (2019) 10.1016/j.molcel.2019.05.034

[37]

Pasqualucci "Inactivating mutations of acetyltransferase genes in B-cell lymphoma" Nature (2011) 10.1038/nature09730

[38]

Chen "Overexpression of p300 correlates with poor prognosis in patients with cutaneous squamous cell carcinoma" Br. J. Dermatol. (2015) 10.1111/bjd.13226

[39]

Sin "p300 mediates muscle wasting in Lewis lung carcinoma" Cancer Res. (2019) 10.1158/0008-5472.can-18-1653

[40]

Li "A CRISPR interference of CBP and p300 selectively induced synthetic lethality in bladder Cancer cells in vitro" Int. J. Biol. Sci. (2019) 10.7150/ijbs.32332

[41]

Mustachio "Repression of GCN5 expression or activity attenuates c-MYC expression in non-small cell lung cancer" Am. J. Cancer Res. (2019)

[42]

Li "PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1" Cancer Lett. (2016) 10.1016/j.canlet.2016.02.053

[43]

Aguilar "Alpha-tubulin K40 acetylation is required for contact inhibition of proliferation and cell-substrate adhesion" Mol. Biol. Cell (2014) 10.1091/mbc.e13-10-0609

[44]

Boggs "Alpha-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration" Cancer Res. (2015) 10.1158/0008-5472.can-13-3563

[45]

Bailey "DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer" Gastroenterology (2014) 10.1053/j.gastro.2013.09.050

[46]

Audia "Histone modifications and Cancer" Cold Spring Harb. Perspect. Biol. (2016) 10.1101/cshperspect.a019521

[47]

Borrow "The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein" Nat. Genet. (1996) 10.1038/ng0996-33

[48]

Chaffanet "MOZ is fused to p300 in an acute monocytic leukemia with t(8;22)" Genes Chromosomes Cancer (2000) 10.1002/(sici)1098-2264(200006)28:2<138::aid-gcc2>3.0.co;2-2

[49]

Valerio "Histone acetyltransferase activity of MOF is required for adult but not early fetal hematopoiesis in mice" Blood (2017) 10.1182/blood-2016-05-714568

[50]

Avvakumov "The MYST family of histone acetyltransferases and their intimate links to cancer" Oncogene (2007) 10.1038/sj.onc.1210608

Showing 50 of 302 references

Cited By

154

HOX genes and tumor metastasis: epigenetic regulatory mechanisms

Junwei Li, Jinhua Yan · 2026

Clinica Chimica Acta

Glucocorticoids elevate clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation

Kenan Zhang, Lin He · 2026

Signal Transduction and Targeted Th...

RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications

Shanhe Huang, Zonglin Li · 2025

MedComm

Epigenetic Alterations in Cancer: The Therapeutic Potential of Epigenetic Drugs in Cancer Therapy

Preeti Gupta · 2025

Drugs and Drug Candidates

Osteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging

Haojue Wang, Tao Yuan · 2024

Aging Cell

From microscopes to molecules: The evolution of prostate cancer diagnostics

Junyue Tao, Xiaokang Bian · 2024

Cytojournal

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

Qian Zhong, Xina Xiao · 2023

MedComm

Metrics

154

Citations

302

References

Details

Published: Aug 01, 2022
Vol/Issue: 83
Pages: 452-471
License: View

Authors

M

Margarita E. Neganova

S

Sergey G. Klochkov

Y

Yulia R. Aleksandrova

G

Gjumrakch Aliev

Funding

Russian Science Foundation Award: 19-73-10195

Cite This Article

Margarita E. Neganova, Sergey G. Klochkov, Yulia R. Aleksandrova, et al. (2022). Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress. Seminars in Cancer Biology, 83, 452-471. https://doi.org/10.1016/j.semcancer.2020.07.015

Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress

You May Also Like